Jasmijn de Rooij

972 total citations
15 papers, 468 citations indexed

About

Jasmijn de Rooij is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Jasmijn de Rooij has authored 15 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Public Health, Environmental and Occupational Health and 5 papers in Molecular Biology. Recurrent topics in Jasmijn de Rooij's work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Protein Degradation and Inhibitors (3 papers). Jasmijn de Rooij is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Protein Degradation and Inhibitors (3 papers). Jasmijn de Rooij collaborates with scholars based in Netherlands, France and Czechia. Jasmijn de Rooij's co-authors include Marry van den Heuvel‐Eibrink, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink, Rob Pieters, Edwin Sonneveld, Jan Trka, Dirk Reinhardt, Todd A. Alonzo, Soheil Meshinchi and Maarten Fornerod and has published in prestigious journals such as Blood, PLoS ONE and Leukemia.

In The Last Decade

Jasmijn de Rooij

13 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasmijn de Rooij Netherlands 8 288 229 153 61 59 15 468
April Sorrell United States 9 314 1.1× 114 0.5× 201 1.3× 90 1.5× 30 0.5× 18 498
Manabu Sotomatsu Japan 12 256 0.9× 164 0.7× 132 0.9× 41 0.7× 45 0.8× 22 393
Mircéa Adam France 8 255 0.9× 134 0.6× 180 1.2× 56 0.9× 30 0.5× 13 378
Yulia Olshanskaya Russia 10 221 0.8× 102 0.4× 138 0.9× 94 1.5× 44 0.7× 82 381
Frauke Bellos Germany 11 254 0.9× 138 0.6× 145 0.9× 98 1.6× 18 0.3× 21 428
Cristina N. Alonso Argentina 11 165 0.6× 91 0.4× 194 1.3× 74 1.2× 34 0.6× 30 384
Bianca F. Goemans Netherlands 10 419 1.5× 200 0.9× 147 1.0× 85 1.4× 28 0.5× 34 563
Mette Skov Holm Denmark 9 451 1.6× 272 1.2× 132 0.9× 94 1.5× 25 0.4× 19 623
Juliane Grimm Germany 14 345 1.2× 115 0.5× 116 0.8× 61 1.0× 29 0.5× 28 485
Bachar Samra United States 9 150 0.5× 97 0.4× 113 0.7× 136 2.2× 58 1.0× 18 364

Countries citing papers authored by Jasmijn de Rooij

Since Specialization
Citations

This map shows the geographic impact of Jasmijn de Rooij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmijn de Rooij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmijn de Rooij more than expected).

Fields of papers citing papers by Jasmijn de Rooij

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmijn de Rooij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmijn de Rooij. The network helps show where Jasmijn de Rooij may publish in the future.

Co-authorship network of co-authors of Jasmijn de Rooij

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmijn de Rooij. A scholar is included among the top collaborators of Jasmijn de Rooij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmijn de Rooij. Jasmijn de Rooij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rooij, Jasmijn de. (2016). Molecular genetic aberrations and their prognostic relevance in pediatric acute myeloid leukemia. Data Archiving and Networked Services (DANS). 1 indexed citations
2.
Buijs, Arjan, Martine van Grotel, Natasja Dors, et al.. (2016). A neonate with a unique non‐Down syndrome transient proliferative megakaryoblastic disease. Pediatric Blood & Cancer. 64(3). 2 indexed citations
3.
Rooij, Jasmijn de, Riccardo Masetti, Marry M. van den Heuvel‐Eibrink, et al.. (2016). Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study. Blood. 127(26). 3424–3430. 72 indexed citations
4.
Verboon, Lonneke, Askar Obulkasim, Jasmijn de Rooij, et al.. (2016). MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia. Oncotarget. 7(30). 48412–48422. 20 indexed citations
5.
Rooij, Jasmijn de, Marry M. van den Heuvel‐Eibrink, Askar Obulkasim, et al.. (2015). Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia. Haematologica. 100(9). 1151–1159. 31 indexed citations
6.
Rooij, Jasmijn de, C. Michel Zwaan, & Marry van den Heuvel‐Eibrink. (2015). Pediatric AML: From Biology to Clinical Management. Journal of Clinical Medicine. 4(1). 127–149. 144 indexed citations
7.
Rooij, Jasmijn de, Riccardo Masetti, Marry M. van den Heuvel‐Eibrink, et al.. (2015). Prognostic Relevance of Recurrent Genetic Aberrations in Pediatric Acute Megakaryoblastic Leukemia. Blood. 126(23). 2598–2598. 2 indexed citations
8.
Rooij, Jasmijn de, Marry M. van den Heuvel‐Eibrink, Wouter J.W. Kollen, et al.. (2015). Recurrent translocation t(10;17)(p15;q21) in minimally differentiated acute myeloid leukemia results in ZMYND11/MBTD1 fusion. Genes Chromosomes and Cancer. 55(3). 237–241. 15 indexed citations
9.
López-López, Elixabet, M.L. te Winkel, Wim J. E. Tissing, et al.. (2014). Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia. The Pharmacogenomics Journal. 15(3). 248–254. 59 indexed citations
10.
López-López, Elixabet, M.L. te Winkel, Wim J. E. Tissing, et al.. (2014). Genetic and Metabolic Determinants of Methotrexate Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia. Blood. 124(21). 939–939. 1 indexed citations
11.
Rooij, Jasmijn de, Maarten Fornerod, Askar Obulkasim, et al.. (2014). ETV6 Aberrations Are a Recurrent Event in Pediatric Acute Myeloid Leukemia with Poor Clinical Outcome. Blood. 124(21). 1012–1012. 4 indexed citations
12.
Rooij, Jasmijn de, C. Michel Zwaan, Askar Obulkasim, et al.. (2014). IKZF1 deletions in Pediatric Acute Myeloid Leukemia. Blood. 124(21). 2346–2346. 1 indexed citations
13.
Rooij, Jasmijn de, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters, et al.. (2013). NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia. 27(12). 2280–2288. 95 indexed citations
14.
Been, Jasper V., Sizzle F. Vanterpool, Jasmijn de Rooij, et al.. (2012). A Clinical Prediction Rule for Histological Chorioamnionitis in Preterm Newborns. PLoS ONE. 7(10). e46217–e46217. 18 indexed citations
15.
Reinhardt, Katarina, C. Michel Zwaan, Michael Dworzak, et al.. (2012). High Frequency of GATA1 Mutations in Childhood Non-Down Syndrome Acute Megakaryoblastic Leukemia. Blood. 120(21). 888–888. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026